Startup profile · funding coverage
Brellium funding, valuation and investors
AI platform that audits clinical documentation and coding before billing.
Keep track of Brellium
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Venture financing
$23 million · October 13, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$23M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · New York, New York, United States
Investors in latest funding
Lead: Left Lane Capital , First Round Capital
Overview
New York-based Brellium provides clinical compliance and revenue-integrity software that reviews patient notes, identifies documentation and coding gaps, and proposes fixes before claims are submitted.
Why Brellium is interesting
Brellium is turning clinical chart review from a small-sample manual process into automated pre-bill infrastructure and is underwriting part of the audit risk through a financial guarantee.
Product & use cases
CortexLM audits clinical notes against provider-specific care, payer and regulatory requirements. The system flags documentation gaps, coding risks and potential missed revenue before billing.
- Pre-bill clinical chart audit
- Clinical documentation compliance
- Coding quality assurance
- Revenue-integrity workflows
Key facts
- $23 million venture financing led by Left Lane Capital and First Round Capital.
- 22 million patient visits audited and nearly $2 billion in provider revenue protected, according to the company.
- More than 215,000 providers and 200 provider groups, according to Brellium.
Funding history (newest first)
Venture financing
2026-10-13 $23 millionSource: https://www.businesswire.com/news/home/20261013296137/en/
Investors in our directory
Funds linked from Brellium's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Full-chart coverage, provider-specific requirements and an audit clawback guarantee align Brellium with provider economics rather than offering generic documentation assistance.
Brellium competes with manual audit teams, revenue-cycle management vendors and clinical documentation integrity software. Adoption depends on model accuracy, explainability, secure handling of protected health information and the economics of its guarantee.
-
Fathom adjacent
AI medical coding platform with adjacent revenue-cycle workflow coverage.
-
CodaMetrix adjacent
Autonomous medical coding and revenue-cycle competitor.
-
Traditional clinical audit vendors incumbent
Manual and rules-based incumbent alternative.
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Brellium's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.